SHPH (STOCKS)
Shuttle Pharmaceuticals Holdings, Inc. Common Stock
$1.137000
-0.343000 (-23.18%)
Prev close: $1.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher Robert Cooper
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.75M
- Employees
- 9
- P/E (TTM)
- -0.05
- P/B (TTM)
- 1.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | -$5.60M |
| Nonoperating Income/Loss | $200.47K |
| Operating Expenses | $10.91M |
| Research and Development | $4.53M |
| Other Operating Expenses | $6.38M |
| Operating Income/Loss | -$10.91M |
| Income/Loss From Continuing Operations After Tax | -$11.09M |
| Income/Loss From Continuing Operations Before Tax | -$11.09M |
| Net Income/Loss | -$11.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$388.30K |
| Net Income/Loss Attributable To Parent | -$10.71M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.71M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $75.89 |
| Diluted Earnings Per Share | $75.78 |
| Basic Average Shares | 4,043,287 |
| Diluted Average Shares | 4,060,435 |
| Assets | $3.54M |
| Current Assets | $3.27M |
| Noncurrent Assets | $277.01K |
| Fixed Assets | $18.33K |
| Other Non-current Assets | $258.69K |
| Liabilities | $2.15M |
| Current Liabilities | $1.96M |
| Noncurrent Liabilities | $183.86K |
| Equity | $1.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.39M |
| Liabilities And Equity | $3.54M |
| Net Cash Flow From Operating Activities | -$11.20M |
| Net Cash Flow From Operating Activities, Continuing | -$11.20M |
| Net Cash Flow From Investing Activities | -$174.50K |
| Net Cash Flow From Investing Activities, Continuing | -$2.59M |
| Net Cash Flow From Financing Activities | $13.14M |
| Net Cash Flow From Financing Activities, Continuing | $13.14M |
| Net Cash Flow | -$656.27K |
| Net Cash Flow, Continuing | -$656.27K |
| Comprehensive Income/Loss | -$11.09M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.09M |
| Other Comprehensive Income/Loss | $0.00 |